Cookies auf der KCI-Website
Wir verwenden Cookies, um Ihnen die Nutzung unserer Website zu erleichtern. Weitere Informationen zu Cookies und deren Verwendung erhalten Sie hier Privacy Policy. Um Ihnen das Navigieren zu erleichtern, empfehlen wir Ihnen, die Cookies zu akzeptieren.
Eingabehilfen | Sitemap | Kontaktieren Sie uns | Service-Hotline 0800/7833524
Deutschland Change Country
Startseite  |  Einsatzgebiete  |  Produkte  |  Klinische Evidenz  |  Fortbildung & Training  |  Für Patienten  |  Kundendienst
Sie sind hier Definition der Strattice Gewebematrix > CelluTome™ Epidermal Harvesting System
Drucken
CelluTome Epidermal Harvesting System
Bild vergrößern

CelluTome™ Epidermal Harvesting System

For additional information on CelluTome™ Epidermal Harvesting System, please visit www.cellutome.com .

To have a KCI representative contact you with additional information on the CelluTome™ Epidermal Harvesting System please complete the following   contact information.


Cellutome Training

Click here to complete our Cellutome training

Mechanism of Action

Autologous epidermal skin grafting is a minimally invasive treatment option for the closure of wounds. Epidermal skin grafting was shown to be successful on superficial, granulated wounds that are free of necrotic tissue and surrounding infection. Watch the mechanism of action video below to learn more.

 

System Overview

The CelluTome Epidermal Harvesting System is intended to reproducibly harvest a thin skin graft for autologous skin grafting.

Device Description

The reusable components of the CelluTome Epidermal Harvesting System:

  • Control Unit

    The Control Unit creates and regulates the vacuum and warming required to raise the epidermal microdomes.

  • Vacuum Head

    The Vacuum Head and tubing deliver the vacuum and warming from the Control Unit.

The disposable component of the CelluTome Epidermal Harvesting System:

  • Harvester

    The Harvester holds the suction microdomes that are raised for procurement. A 3M Tegaderm Film (catalog number: 1624W) is inserted into the Harvester prior to cutting the microdomes. The 3M Tegaderm Film with the microdomes is then applied to the recipient site.

 

NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for KCI products and therapies. Before use, physicians must review all risk information and essential prescribing information which can be found in the CelluTome™ Epidermal Harvesting System Instructions for Use. Rx only.

Procedure Overview

The CelluTome System produces an array of epidermal micrografts ready for immediate transfer onto a recipient site.

Please click on the patient procedural video below:

  • CelluTome™ Epidermal Harvesting System Procedural Video (DSL#13-0256.US(4/13))
 

Automated, uniform process

4.9X magnification of a microdome array section

The harvesting procedure is precise and reproducible, raising uniform microdomes (photo: Full microdome formation, optimal microdome height with clear fluid encapsulated in microdome, ready to harvest into micrografts.)

Effective harvesting procedure

Histological microdome cross-section; 100X magnification. BK = basal layer keratinocyte; SC = stratum corneum.

The CelluTome™ System consistently harvests epidermis at the dermal-epidermal junction, including basal keratinocytes. (photo: Histological microdome cross-section; 100X magnification. BK = basal layer keratinocyte; SC = stratum corneum.)

Viable Epithelium for Skin Grafting

LIVE/DEAD® stained epidermal microdome with Calcein AM dye; green staining indicates live cells.

The micrografts harvested contain undamaged tissue for grafting to a recipient site. (photo: LIVE/DEAD® stained epidermal micrograft with Calcein AM dye; green staining indicates live cells.)

Cell Proliferation

Keratinocyte outgrowth over time, cultured in EpiLife® medium (cytoskeleton, green; plasma membrane, red; nucleus, blue; 100X magnification)

Cells grow outwards from the micrograft edge demonstrating that the cells are not damaged during acquisition. (photo: Keratinocyte outgrowth over time, cultured in EpiLife® Medium. cytoskeleton, green; plasma membrane, red; nucleus, blue; 100X magnification)

 

3M and Tegaderm are trademarks of 3M Company. EpiLife and Live/Dead are trademarks of Life Technologies Corporation. All other trademarks designated herein are proprietary to KCI Licensing, Inc., its affiliates and/or licensors. DSL#13-0010.US.CT (7/13)

 

US Reimbursement

Reimbursement Education Hotline Services

KCI is committed to providing customer service to clinical providers and healthcare facilities that use KCI products, including product reimbursement resources. The Reimbursement Education Hotline is staffed by reimbursement specialists to offer assistance with the following:

KCI Reimbursement Education Hotline is available from Monday to Friday, 8 a.m. – 8 p.m., EST

Tel: 800-668-6812
Fax: 800-311-9291
Email: ReimbursementEducation@KCI1.com

Disclaimer:

The information provided by KCI is general reimbursement information only. It is not legal advice, nor is it advice about how to code, complete or submit any particular claim for payment. Although we supply this information for your convenience, it is the provider’s responsibility to determine and submit appropriate codes, charges, modifiers, and bills for services rendered. Payors or their regional offices may have their own coding and reimbursement requirements and policies. Before filing any claims, providers should verify current requirements and policies with the payor.

Ordering Information

For complete safety information, instructions for use, warnings, precautions, contraindications, please reference the Instructions for Use.

To order, please call 1-800-275-4524

To schedule a product demonstration, please complete the following contact information.

SKU/Part Number Description
CT-CUl/US CelluTome Control Unit
CT-VHl CelluTome Vacuum Head
CT-CUSl CelluTome Control Unit Stand
CT-TFLM Tegaderm Film
CT-H25 CelluTome Harvester 2.5cm 5-pack
CT-H5O CelluTome Harvester 5.0cm 5-pack

 


  • Share on Facebook.com
  • Share on Twitter
  • Besuchen Sie unsere YourTube Seite

Wichtige Mitteilung für Patienten

Rechtliches | Datenschutzrichtlinien | Kontaktieren Sie uns | Impressum


© 1998 – 2013 KCI Licensing, Inc. Alle Rechte vorbehalten.    DSL# 09-03-193.DE

Die Informationen auf dieser Website wurden ausschließlich zur Nutzung in Deutschland / KCI Medizinprodukte GmbH bereitgestellt. Diese Website enthält Informationen über Produkte, die möglicherweise nicht in allen Ländern verfügbar sind. Es ist außerdem möglich, dass sie von den zuständigen Behörden in bestimmten Ländern noch nicht oder nicht für bestimmte Indikationen zugelassen sind.